stoxline Quote Chart Rank Option Currency Glossary
GRI Bio, Inc. (GRI)
0.84  -0.04 (-4.53%)    02-27 14:13
Open: 0.861
High: 0.8654
Volume: 233,408
Pre. Close: 0.8799
Low: 0.7926
Market Cap: 1(M)
Technical analysis
2024-02-27 2:14:42 PM
Short term     
Mid term     
Targets 6-month :  3.94 1-year :  5.84
Resists First :  3.37 Second :  5
Pivot price 1.06
Supports First :  0.75 Second :  0.62
MAs MA(5) :  0.87 MA(20) :  1.26
MA(100) :  4.68 MA(250) :  27.9
MACD MACD :  -0.4 Signal :  -0.4
%K %D K(14,3) :  12.4 D(3) :  8.7
RSI RSI(14): 30.6
52-week High :  133.97 Low :  0.75
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ GRI ] has closed above bottom band by 15.5%. Bollinger Bands are 74.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.94 - 0.95 0.95 - 0.95
Low: 0.78 - 0.78 0.78 - 0.78
Close: 0.87 - 0.88 0.88 - 0.89
Company Description

GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was incorporated in 2009 and is based in LA Jolla, California.

Headline News

Sat, 03 Feb 2024
GRI Bio Launches Major Securities Public Offering - - TipRanks

Fri, 02 Feb 2024
Form 424B3 GRI BIO, Inc. -

Fri, 02 Feb 2024
GRI Bio sets terms for $5.5 million public offering By -

Fri, 02 Feb 2024
GRI Bio Announces Pricing of $5.5 Million Public Offering - GlobeNewswire

Fri, 02 Feb 2024
GRI Bio, Inc. Announces Pricing of Public Offering to Raise $5.5M - BNN Breaking

Fri, 02 Feb 2024
GRI Bio Skids on Pricing Public Offering -

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 1 (M)
Shares Float 0 (M)
Held by Insiders 17.7 (%)
Held by Institutions 4.5 (%)
Shares Short 53 (K)
Shares Short P.Month 21 (K)
Stock Financials
EPS -31.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.26
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -292.5 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -11.04
Qtrly Earnings Growth 0 %
Operating Cash Flow -4 (M)
Levered Free Cash Flow -6 (M)
Stock Valuations
PE Ratio -0.03
PEG Ratio 0
Price to Book value 0.15
Price to Sales 0
Price to Cash Flow -0.2
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android